Detecting Tumor DNA in Ovarian Cancer Using Whole-Genome Sequencing
Author Information
Author(s): Christine Fribert Thusgaard, Sepideh Sadegh, Kirsten Marie Jochumsen, Torben Arvid Kruse, Mads Thomassen
Primary Institution: Odense University Hospital
Hypothesis
Can a tumor-informed method improve the detection of circulating tumor DNA in ovarian cancer patients?
Conclusion
The study presents a promising method for detecting circulating tumor DNA in ovarian cancer patients, showing significant potential for improving signal detection.
Supporting Evidence
- The method showed a considerable improvement in ctDNA signal detection using a plasma pool filter.
- Circulating tumor DNA was detectable even at a reduced sequencing depth.
- The study included 10 patients with high-grade serous ovarian cancer.
Takeaway
Researchers found a new way to detect cancer DNA in the blood of ovarian cancer patients, which could help doctors see how well treatment is working.
Methodology
The study used whole-genome sequencing to analyze tumor and plasma samples from ovarian cancer patients, applying various filtering methods to improve detection of circulating tumor DNA.
Potential Biases
There is a slight risk that true recurrent mutations could be removed by the plasma pool filter.
Limitations
The study had a small sample size and all tumor samples had a high tumor cell fraction, which may not represent all patients.
Participant Demographics
Patients with high-grade serous ovarian cancer, with a tumor cell fraction of at least 75%.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website